1. Home
  2. AVXL vs SMBC Comparison

AVXL vs SMBC Comparison

Compare AVXL & SMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • SMBC
  • Stock Information
  • Founded
  • AVXL 2004
  • SMBC 1887
  • Country
  • AVXL United States
  • SMBC United States
  • Employees
  • AVXL N/A
  • SMBC N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • SMBC Banks
  • Sector
  • AVXL Health Care
  • SMBC Finance
  • Exchange
  • AVXL Nasdaq
  • SMBC Nasdaq
  • Market Cap
  • AVXL 635.6M
  • SMBC 613.1M
  • IPO Year
  • AVXL N/A
  • SMBC N/A
  • Fundamental
  • Price
  • AVXL $3.71
  • SMBC $54.14
  • Analyst Decision
  • AVXL Strong Buy
  • SMBC Hold
  • Analyst Count
  • AVXL 3
  • SMBC 4
  • Target Price
  • AVXL $33.00
  • SMBC $63.63
  • AVG Volume (30 Days)
  • AVXL 2.9M
  • SMBC 76.1K
  • Earning Date
  • AVXL 12-22-2025
  • SMBC 10-22-2025
  • Dividend Yield
  • AVXL N/A
  • SMBC 1.69%
  • EPS Growth
  • AVXL N/A
  • SMBC 25.22
  • EPS
  • AVXL N/A
  • SMBC 5.46
  • Revenue
  • AVXL N/A
  • SMBC $178,892,000.00
  • Revenue This Year
  • AVXL N/A
  • SMBC $17.00
  • Revenue Next Year
  • AVXL N/A
  • SMBC $4.72
  • P/E Ratio
  • AVXL N/A
  • SMBC $9.97
  • Revenue Growth
  • AVXL N/A
  • SMBC 10.39
  • 52 Week Low
  • AVXL $2.86
  • SMBC $45.10
  • 52 Week High
  • AVXL $14.44
  • SMBC $68.69
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 14.26
  • SMBC 57.51
  • Support Level
  • AVXL $6.35
  • SMBC $52.52
  • Resistance Level
  • AVXL $7.25
  • SMBC $55.57
  • Average True Range (ATR)
  • AVXL 0.64
  • SMBC 1.26
  • MACD
  • AVXL -0.34
  • SMBC 0.26
  • Stochastic Oscillator
  • AVXL 14.49
  • SMBC 73.97

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About SMBC Southern Missouri Bancorp Inc.

Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.

Share on Social Networks: